Join to view full profile
Stanford Cancer Center875 Blake Wilbur Drive, CC2221Palo Alto, CA 94304
Phone+1 650-725-8630
Dr. Thomas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Reena Thomas, MD, PhD is a Neurology specialist based in Palo Alto, CA at Stanford Medicine, with a subspecialty in Neurooncology. She completed her medical education at Georgetown University School of Medicine and further training at Stanford University, including a residency in Neurology and a fellowship in Neuro-Oncology. Dr. Thomas is a Clinical Professor and Senior Associate Dean at Stanford University School of Medicine. Her areas of expertise include Neuro Oncology and translational immunotherapy research using CAR T in glioblastoma.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Neuro-Oncology, 2013 - 2014- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2010 - 2013
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2009 - 2010
Georgetown University School of MedicineClass of 2009
Cornell UniversityBA, Biology, Neurobiology, 1998 - 2002
Certifications & Licensure
CA State Medical License 2011 - 2028
VA State Medical License 2009 - 2011
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- [F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade glioma.Alexander Khalaf, Lewis Naya, Lesley Flynt, Devaki Shilpa Surasi, Yang Lu
Neuroradiology. 2026-06-01 - 1 citationsEtirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.Seema Nagpal, Kim-Son Nguyen, Sophie Bertrand, Kristen May Cunanan, Sukhmani K Padda
Cancer Reports. 2025-09-01 - From conference to career: Tracing medical pathways of Stanford university's minority medical alliance (SUMMA) premedical conference alumni.Aneysis D Gonzalez-Suarez, Emily Moya, Felipe D Perez, Mark Gutierrez, Reena P Thomas
Journal of the National Medical Association. 2025-06-01
Press Mentions
Reckoningwith Health’ssocial ContextJanuary 23rd, 2023- It’s Not Rocket Science — It’s HarderMay 10th, 2021
- CIRM Invests Nearly $44 Million to Advance Regenerative Medicine Research and Manufacturing in CaliforniaSeptember 30th, 2023
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
